These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 26227106)

  • 1. Nonchimeric HLA-Identical Renal Transplant Tolerance: Regulatory Immunophenotypic/Genomic Biomarkers.
    Leventhal JR; Mathew JM; Salomon DR; Kurian SM; Friedewald JJ; Gallon L; Konieczna I; Tambur AR; Charette J; Levitsky J; Jie C; Kanwar YS; Abecassis MM; Miller J
    Am J Transplant; 2016 Jan; 16(1):221-34. PubMed ID: 26227106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA identical non-chimeric and HLA disparate chimeric renal transplant tolerance.
    Leventhal JR; Mathew JM; Ildstad S; Salomon DR; Kurian SM; Suthanthiran M; Tambur A; Friedewald J; Gallon L; Charette J; Levitsky J; Kanwar Y; Abecassis M; Miller J
    Clin Transpl; 2013; ():145-56. PubMed ID: 25095503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updated follow-up of a tolerance protocol in HLA-identical renal transplant pairs given donor hematopoietic stem cells.
    Leventhal JR; Miller J; Mathew JM; Kurian S; Tambur AR; Friedewald J; Charrette J; Abecassis MM
    Hum Immunol; 2018 May; 79(5):277-282. PubMed ID: 29408689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic biomarkers correlate with HLA-identical renal transplant tolerance.
    Leventhal JR; Mathew JM; Salomon DR; Kurian SM; Suthanthiran M; Tambur A; Friedewald J; Gallon L; Charette J; Levitsky J; Kanwar Y; Abecassis M; Miller J
    J Am Soc Nephrol; 2013 Sep; 24(9):1376-85. PubMed ID: 23787913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical strategy for induction of transplantation tolerance through mixed chimerism.
    Cosimi AB; Sachs DH; Sykes M; Kawai T
    Clin Transpl; 2013; ():127-34. PubMed ID: 25095501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune reconstitution/immunocompetence in recipients of kidney plus hematopoietic stem/facilitating cell transplants.
    Leventhal JR; Elliott MJ; Yolcu ES; Bozulic LD; Tollerud DJ; Mathew JM; Konieczna I; Ison MG; Galvin J; Mehta J; Badder MD; Abecassis MM; Miller J; Gallon L; Ildstad ST
    Transplantation; 2015 Feb; 99(2):288-98. PubMed ID: 25594553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twenty-year Follow-up of Histocompatibility Leukocyte Antigen-matched Kidney and Bone Marrow Cotransplantation for Multiple Myeloma With End-stage Renal Disease: Lessons Learned.
    Spitzer TR; Tolkoff-Rubin N; Cosimi AB; McAfee S; Dey BR; Chen YB; Delmonico F; Sykes M; Sachs DH; Kawai T
    Transplantation; 2019 Nov; 103(11):2366-2372. PubMed ID: 30801529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated Injections of IL-2 Break Renal Allograft Tolerance Induced via Mixed Hematopoietic Chimerism in Monkeys.
    Yamada Y; Nadazdin O; Boskovic S; Lee S; Zorn E; Smith RN; Colvin RB; Madsen JC; Cosimi AB; Kawai T; Benichou G
    Am J Transplant; 2015 Dec; 15(12):3055-66. PubMed ID: 26190648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful Induction of Specific Immunological Tolerance by Combined Kidney and Hematopoietic Stem Cell Transplantation in HLA-Identical Siblings.
    Fehr T; Hübel K; de Rougemont O; Abela I; Gaspert A; Güngör T; Hauri M; Helmchen B; Linsenmeier C; Müller T; Nilsson J; Riesterer O; Scandling JD; Schanz U; Cippà PE
    Front Immunol; 2022; 13():796456. PubMed ID: 35173720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune monitoring of transplant patients in transient mixed chimerism tolerance trials.
    Sykes M
    Hum Immunol; 2018 May; 79(5):334-342. PubMed ID: 29289741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers of Tolerance in Kidney Transplantation: Are We Predicting Tolerance or Response to Immunosuppressive Treatment?
    Rebollo-Mesa I; Nova-Lamperti E; Mobillo P; Runglall M; Christakoudi S; Norris S; Smallcombe N; Kamra Y; Hilton R; ; Bhandari S; Baker R; Berglund D; Carr S; Game D; Griffin S; Kalra PA; Lewis R; Mark PB; Marks S; Macphee I; McKane W; Mohaupt MG; Pararajasingam R; Kon SP; Serón D; Sinha MD; Tucker B; Viklický O; Lechler RI; Lord GM; Hernandez-Fuentes MP
    Am J Transplant; 2016 Dec; 16(12):3443-3457. PubMed ID: 27328267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Origin of Enriched Regulatory T Cells in Patients Receiving Combined Kidney-Bone Marrow Transplantation to Induce Transplantation Tolerance.
    Sprangers B; DeWolf S; Savage TM; Morokata T; Obradovic A; LoCascio SA; Shonts B; Zuber J; Lau SP; Shah R; Morris H; Steshenko V; Zorn E; Preffer FI; Olek S; Dombkowski DM; Turka LA; Colvin R; Winchester R; Kawai T; Sykes M
    Am J Transplant; 2017 Aug; 17(8):2020-2032. PubMed ID: 28251801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-mismatched renal transplantation without maintenance immunosuppression.
    Kawai T; Cosimi AB; Spitzer TR; Tolkoff-Rubin N; Suthanthiran M; Saidman SL; Shaffer J; Preffer FI; Ding R; Sharma V; Fishman JA; Dey B; Ko DS; Hertl M; Goes NB; Wong W; Williams WW; Colvin RB; Sykes M; Sachs DH
    N Engl J Med; 2008 Jan; 358(4):353-61. PubMed ID: 18216355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic hematopoietic stem-cell transplantation, mixed chimerism, and tolerance in living related donor renal allograft recipients.
    Trivedi HL; Vanikar AV; Modi PR; Shah VR; Vakil JM; Trivedi VB; Khemchandani SI
    Transplant Proc; 2005 Mar; 37(2):737-42. PubMed ID: 15848518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor Specificity but Not Broadness of Sensitization Is Associated With Antibody-Mediated Rejection and Graft Loss in Renal Allograft Recipients.
    Wehmeier C; Hönger G; Cun H; Amico P; Hirt-Minkowski P; Georgalis A; Hopfer H; Dickenmann M; Steiger J; Schaub S
    Am J Transplant; 2017 Aug; 17(8):2092-2102. PubMed ID: 28245084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Ex Vivo-Expanded Recipient Regulatory T Cells on Hematopoietic Chimerism and Kidney Allograft Tolerance Across MHC Barriers in Cynomolgus Macaques.
    Duran-Struuck R; Sondermeijer HP; Bühler L; Alonso-Guallart P; Zitsman J; Kato Y; Wu A; McMurchy AN; Woodland D; Griesemer A; Martinez M; Boskovic S; Kawai T; Cosimi AB; Yang YG; Hu Z; Wuu CS; Slate A; Mapara M; Baker S; Tokarz R; D'Agati V; Hammer S; Pereira M; Lipkin WI; Wekerle T; Levings M; Sykes M
    Transplantation; 2017 Feb; 101(2):274-283. PubMed ID: 27846155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants.
    Chandran S; Tang Q; Sarwal M; Laszik ZG; Putnam AL; Lee K; Leung J; Nguyen V; Sigdel T; Tavares EC; Yang JYC; Hellerstein M; Fitch M; Bluestone JA; Vincenti F
    Am J Transplant; 2017 Nov; 17(11):2945-2954. PubMed ID: 28675676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex Vivo Costimulatory Blockade to Generate Regulatory T Cells From Patients Awaiting Kidney Transplantation.
    Guinan EC; Cole GA; Wylie WH; Kelner RH; Janec KJ; Yuan H; Oppatt J; Brennan LL; Turka LA; Markmann J
    Am J Transplant; 2016 Jul; 16(7):2187-95. PubMed ID: 26790369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological picture of antibody-mediated rejection without donor-specific anti-HLA antibodies: Clinical presentation and implications for outcome.
    Senev A; Coemans M; Lerut E; Van Sandt V; Daniëls L; Kuypers D; Sprangers B; Emonds MP; Naesens M
    Am J Transplant; 2019 Mar; 19(3):763-780. PubMed ID: 30107078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of protocol kidney biopsies for de novo donor-specific antibodies.
    Parajuli S; Reville PK; Ellis TM; Djamali A; Mandelbrot DA
    Am J Transplant; 2017 Dec; 17(12):3210-3218. PubMed ID: 28805293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.